Abstract: A beamformer for an ultrasound system and a method for developing a beamformer are provided. The beamformer includes an RF interface configured to be connected to receiver boards that are connected to a probe. The method includes providing receiver boards, wherein each of the receiver boards is capable of conveying a common number of channels per board and has substantially similar circuit components and layouts. The method also includes selecting a number of channels per probe to be conveyed in parallel between a probe and the receiver boards, wherein the channels per probe is an integer multiple of the channels per board. The method further includes determining a combination of the receiver boards to use in the beamformer based on the number of channels per probe, wherein the receiver boards are capable of being used in at least first and second different combinations that support first and second different numbers of channels per probe.

Abstract: A method is provided to perform network access control. A computing device utilising Online Certificate Status Protocol responder functionality determines whether attempted communication should be allowed between other computing devices appropriately configured with Internet Protocol Security (IPsec), digital certificates and OCSP client software. This determination is based on a set of rules considering the role or roles of the computing devices attempting to communicate, and whether the computing devices attempting to communicate have previously exhibited suspicious or undesirable behaviour.

Abstract: Embodiments of the present invention are directed to providing and controlling illumination for three-dimensional structured illumination microscopy. Three phase-coherent beams, referred to as a “beam triplet,” are produced with planar beamsplitters. The relative phases of the beams are controlled by piezo-coupled mirrors or other means. The beams pass through the microscope objective and interfere to produce the 3D structured illumination pattern. The spatial orientation and location of the pattern is manipulated by adjusting the relative phases of the beams.

Abstract: This invention relates generally to the field of medicine and, more specifically, to methods for treating epithelial injury, in particular, due to ischemia, hypoxia, trauma, chemolytics or radiation exposure.

Abstract: A nutritionally complete infant formula containing sialic acid derived from one or a number of nutritionally appropriate sources is described.

Abstract: Methods of and equipment for converting existing standard motion picture theatres to one having highly immersive, large fields of view are addressed. Aspects of the methods including moving motion picture screens closer to the audience and employing different projection equipment to avoid or minimize appearance of unrealistic or non-natural image artefacts. Alternative sound systems too are detailed.

Abstract: A process of priming mature, imbibed, germinated somatic embryos of a conifer species. The process comprises fully immersing mature, imbibed, germinated somatic conifer embryos in a sterile liquid nutrient medium, bubbling an oxygen-containing gas through the liquid nutrient medium containing the germinants to form an aerated embryo-containing nutrient medium, optionally exposing the aerated germinant-containing nutrient medium to light, at least intermittently, continuing the immersion, bubbling and optional exposure to light for a period of time effective to produce at least some successfully primed conifer germinants that are adapted for subsequent planting and conversion to viable seedlings, and removing the successfully primed conifer germinants from the nutrient medium.

Abstract: Disclosed are compounds of Formula (I) and pharmaceutically acceptable salts and solvates thereof. Such compounds are MEK inhibitors and are useful in the treatment of proliferative diseases, such as cancer. Also disclosed are pharmaceutical compositions containing such compounds as well as methods of using the compounds and compositions of the invention in the treatment of cancer.

Abstract: This invention relates to a novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its use in the manufacture of pharmaceutical compositions. The compound of the invention is found to be a cholinergic ligand at the nicotinic acetylcholine receptors. Due to its pharmacological profile the compound of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.

Abstract: The present invention relates to compounds of the Formula I, wherein G, A, X1, X2, X3, Z, E, Y, and X are defined herein. The compounds modulate protein kinase enzymatic activity to modulate cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. Compounds of the invention inhibit, regulate and/or modulate kinases, particularly Raf. Methods of using and preparing the compounds, and pharmaceutical compositions thereof, to treat kinase-dependent diseases and conditions are also an aspect of the invention.

Abstract: Methods of and equipment for converting existing standard motion picture theatres to one having highly immersive, large fields of view are addressed. Aspects of the methods including moving motion picture screens closer to the audience and employing different projection equipment to avoid or minimize appearance of unrealistic or non-natural image artifacts. Alternative sound systems too are detailed.

Abstract: This invention relates to novel 8,10-diaza-bicyclo[4.3.1]decane derivatives, which are found to be cholinergic ligands at the nicotinic acetylcholine receptors. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.

Abstract: The invention provides a nutrient medium useful for sowing a somatic plant embryo or germinant of conifer species, which comprises particles of a solid component present within a flowable or semi-solid component containing water and a carbohydrate nutrient for the embryos or germinants. The nutrient medium has a fluidity such that at least some of the flowable or semi-solid component containing the carbohydrate nutrient remains in contact with the embryos or germinant at least until the embryo or germinant establishes vigorous growth under environmental conditions effective for such growth. The particles of the solid component are adapted to remain in contact with the embryo or germinant after of the flowable or semi-solid material dissipates, thereby providing continuing physical support for the embryo or germinant after the dissipation.

Abstract: The present invention is directed to a test probe having an indexable probe tip. In one embodiment, an insulative sleeve extends from the test probe and surrounds a portion of the exposed probe tip. The insulative sleeve is moveable relative to the probe tip and may be indexable to at least two positions. For instance, the insulative sleeve locks into a first position to provide a first length of the probe tip exposed from the insulative sleeve, and the insulative sleeve locks into a second position to provide a second length of the probe tip exposed from the insulative sleeve.

Abstract: Embodiments described herein include generating a navigable medical history corresponding to a patient. Reference information related to medical records for the patient is stored in a referenced records database based on a standardized healthcare code in the medical records. The reference information is inserted into the referenced records database by the medical history system. The medical history system generates the navigable medical history associated with the patient based on the reference information.

Abstract: One or more complex lipids including gangliosides to achieve particular health benefits including maintaining or increasing cognitive development or maintaining or increasing growth in a foetal, infant or child subject.

Abstract: A nutritionally complete infant formula containing sialic acid derived from one or a number of nutritionally appropriate sources is described.

Abstract: A prefabricated wall panel has a top frame structure defining an upward-opening channel extending lengthwise along the upper edge of the panel. An elongate header member is normally disposed within this channel. The header member is vertically slidably supported on supports fixed to the top frame structure so that the header member, in a storage position, is retained in the space. When the panel has been swung upwardly so that the upper edge is aligned below a preinstalled ceiling track, then the header member is manually displaced upwardly until the header telescopes over the ceiling track. A fixed connection is then formed between the header and the ceiling track to provide lateral stability at the upper edge of the wall panel.

Abstract: The present invention relates to systems, methods, data structures and user interfaces for generating and presenting information as to how and why the book yield of an investment portfolio changed over a time interval. Dynamic book yield analysis is particularly useful for bond portfolio analysis and management. Transactions and events that occur in a financial market during a pre-specified time period and relating to a portfolio of assets are identified by a computer server. Specifically, the book yields and book values for these transactions and events are accessed from the portfolio accounting system and the data for each transaction/event are categorized according to transaction/event type (though net cash equivalents are first separated out into their own category). The categorized information is then stored in a data structure residing on the system.

Abstract: This invention relates to novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their use in the manufacture of pharmaceutical compositions. The compounds of the invention are found to be cholinergic ligands at the nicotinic acetylcholine receptors. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.